MCHP Shorts Ease as Analysts Trim Targets Ahead of November Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Microchip Technology is one of the least crowded names in its semiconductor peer group right now, even as the sector broadly rallies into earnings season.
Short interest at just under 5.9% of free float places MCHP below several close peers. DIOD and ADI both carry heavier short positioning relative to their floats, while TXN has attracted the most aggressive near-term buying in the group, up 11.2% on the week against MCHP's 5.7% gain. The peer median weekly move sits at roughly 5.9%, so MCHP is essentially in line with the pack, not leading it. What distinguishes MCHP is the direction of its short positioning: bears have been stepping back. Short interest fell 6.7% over the past week and is now down 7.5% over the past month, pulling the position from around 35 million shares in early October to just under 31.7 million. That is a meaningful reduction, not noise.
The lending market offers no tension at all. Availability runs at roughly 3,090%, meaning there are more than thirty shares available to borrow for every one already lent out. Cost to borrow is 0.41%, well within normal range, and even with the month-over-month doubling in borrow cost from very low September levels, the absolute figure remains inconsequential. This is a stock where short sellers face no mechanical pressure and the borrow market is not a story. The ORTEX short score has also drifted lower through October, from 42.7 on October 22 to 40.9 today, consistent with the unwinding of short positions rather than any renewed buildup.
Options positioning has shifted modestly more cautious without reaching an extreme. The put/call ratio is at 0.57, about 1.4 standard deviations above its 20-day average of 0.53. That is elevated but well short of the 52-week high of 1.03, and the shift appears to have happened steadily over the past two weeks rather than in a single event-driven spike. It reads more like quiet hedging ahead of the November 5 earnings date than a directional bet.
Analyst sentiment is where the more interesting divergence sits. The Street has spent the past week trimming targets without cutting ratings. B. Riley lowered its target to $98 from $108 while keeping a Buy rating. Wells Fargo cut to $80 from $88, maintaining Equal-Weight. TD Cowen moved to $75 from $90, also a Hold. All three actions came after MCHP reported 1QF27 results showing revenue of $1.485 billion, non-GAAP gross margin of 63.8%, and free cash flow of $478.6 million. The bull case rests on data center momentum, where sales rose 97.8% year on year, and on a broadening demand recovery across industrial and consumer end markets. The bear case centres on the 53% revenue exposure to a highly competitive MCU market, where even modest share losses carry real consequences for top-line growth. The mean price target across the analyst community is $105.92, roughly 32% above the current $80.17 close, though several recent cuts suggest targets are still converging toward a lower baseline. Valuation multiples have ticked up with the stock: PE has risen about 0.6 points over the past week to 18.1x, and EV/EBITDA has moved similarly to 15.3x. Neither looks stretched for a mid-cycle semiconductor recovery.
BlackRock filed an updated Schedule 13G on October 27, lifting its declared stake to 11.6% from 10.0%, the most recent move among major holders. Vanguard entities collectively account for another 13% across separately filed positions. There are no 13D activist holders on the register. The institutional base is large, passive, and stable. Insider activity over the past 90 days has been modest net selling of around $377,000, driven primarily by the CFO's planned 10b5-1 sale in late August, not a discretionary signal.
The November 5 earnings date is the obvious next marker. The two most recent post-earnings moves were a 3.9% decline the day after the August 2026 print and an 8.9% jump following the prior quarter's results, so the stock has shown it can move sharply in either direction. Watch whether the ongoing target-price compression from analysts stabilises or continues after the print, and whether short interest, now at its lowest level in more than a month, begins to rebuild if the results disappoint.
Stocks in this article
See the live data behind this article on ORTEX.
Open MCHP on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 18:36
- Data as of
- 28 Oct 2026, 18:34
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.